Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dong-A conducts phase II study with DA-8010 in overactive bladder

July 31, 2018

Mitobridge describes new ACMSD inhibitors

July 26, 2018

SSAO inhibitors identified at Ube Industries

July 25, 2018

Active substance in ROSgard protects kidney tissue in preclinical acute kidney injury study

July 24, 2018

Reata reports promising phase II data from bardoxolone trials in chronic kidney disease

July 24, 2018

Bridge Medicines and Memorial Sloan Kettering partner on platform to deliver drugs to kidneys

July 24, 2018

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

July 19, 2018

Novel CD-1db/db mouse model of type 2 diabetes with progressive kidney fibrosis

July 18, 2018

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

July 17, 2018

Novel surgically induced rat model of diabetic nephropathy

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...